NCT03126123

Brief Summary

Anal condylomatosis is an anal canal mucosa pathology caused by HPV infection (Human Papilloma Virus). This condition is common, especially in immunodepressed patients. These lesions are not accessible to topical medical treatment because of their location. They should be treated surgically because they may degenerate into squamous cell carcinoma. In the operating room, lesions are identified by a complete proctologic examination, more or less supplemented by an acetic acid test. Acetic acid allows to detect mucous degeneration (dysplasia) in the form of intense bleaching. The interpretation of this test may nevertheless be difficult in case of local inflammation or scarring. These false positives may lead to unnecessary surgical gestures. The surgical procedure consists of a mucosectomy or destruction of the condylomatosis by electrocoagulation. The acetic acid test is used at the discretion of the surgeon. However, there is little data on its performance or consensus on its use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 19, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

January 14, 2019

Status Verified

January 1, 2019

Enrollment Period

1.4 years

First QC Date

April 19, 2017

Last Update Submit

January 11, 2019

Conditions

Keywords

Anal condylomatosissurgeryacetic aciddysplastic areas

Outcome Measures

Primary Outcomes (1)

  • Positive predictive value of the acetic acid test in comparison with the anatomopathological analysis of the biopsies performed on the lesions revealed by acetic acid

    Application of acetic acid just before surgery to identify suspect areas of dysplasia. Biopsies of suspicious areas bleached with acetic acid. The true positives (TP) will correspond to lesions bleached by acetic acid and showing dysplasia at biopsy. False positives (FP) will correspond to lesions bleached by acetic acid but not showing dysplasia at biopsy. The positive predictive value (PPV) will be the proportion of TP over the total number of bleached lesions. (PPV = TP / (TP + FP)). The PPV will be given with its 95% confidence interval (95%CI).

    the day of surgery

Secondary Outcomes (7)

  • Evaluation of the toxicity of the acetic acid test

    the day of surgery

  • Identify a patient subgroup in which the acetic acid test would be particularly discriminatory

    up to 5 months before surgery

  • post-surgery pain

    up to 1 month post surgery

  • change in post-surgery incontinence

    up to 5 months before surgery and 1 month post surgery

  • Clinical recurrence of anal condylomatosis

    1 month post surgery

  • +2 more secondary outcomes

Study Arms (1)

acetic acid test

OTHER

Patients will receive surgical treatment for anal condylomatosis and acetic acid on the mucosa of the anal canal before the surgical procedure

Procedure: acetic acid test

Interventions

Patients will receive acetic acid on the mucosa of the anal canal before the surgical procedure

acetic acid test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • programmed surgery for anal condylomatosis in the visceral surgery department of the Hôpital de la Croix Rousse in Lyon
  • patient in receipt of the social security scheme
  • patient who did not oppose his participation in the study.

You may not qualify if:

  • Pregnant women
  • Patients protected by law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital de la Croix Rousse

Lyon, 69004, France

Location

Study Officials

  • Benjamin Darnis

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2017

First Posted

April 24, 2017

Study Start

March 7, 2017

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

January 14, 2019

Record last verified: 2019-01

Locations